Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,048 across all filing types
Latest filing 2011-05-17 Share Issue/Capital Cha…
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
Appendix 3B Issue and exercise of options 6 pages 372.0KB
Share Issue/Capital Change Classification · 100% confidence The document is a detailed announcement regarding the issue, exercise, and lapse of options under employee share option plans, including the number of securities issued, exercise prices, expiry dates, and compliance with relevant sections of the Corporations Act. It includes an Appendix 3B, which is a standard form used for new issue announcements and applications for quotation of additional securities on the ASX. The document does not contain financial statements or management discussion but is focused on capital changes related to share options and share issuance. Therefore, it fits the category of a Share Issue/Capital Change announcement rather than a full financial report or other types of filings.
2011-05-17 English
Nanosonics Management Changes 1 page 61.4KB
Board/Management Information Classification · 100% confidence The document is a company announcement dated 16 May 2011 from Nanosonics Limited regarding changes in the company's management. It announces the resignation of the CEO and the appointment of an interim CEO, along with other senior management appointments. There is no financial data, report, or regulatory filing referenced beyond management changes. The content clearly fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2011-05-15 English
North American contract executed with GE Healthcare 1
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 16 May 2011 from Nanosonics Limited, reporting the execution of a contract with GE Healthcare for distribution rights of a product. It is a brief announcement about a commercial agreement and market strategy, with no financial statements, regulatory filings, or detailed financial data. The document length is only 2500 characters, indicating it is a short announcement rather than a full report. There is no indication of an earnings release, annual or interim report, or other detailed filings. This fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and company news that do not fit other specific categories.
2011-05-15 English
Change of Director`s Interest Notice 2 pages 265.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and details changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the interest, and the value of the transaction. It references ASX listing rules and the Corporations Act, indicating it is a regulatory filing related to insider trading or director share transactions. The document is short (3781 characters) and focuses solely on the director's dealings in shares, with no financial statements or broader company financial information. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). Therefore, the correct classification is DIRS.
2011-05-08 English
Appendix 3B Issue of Shares under DESP 6 pages 383.0KB
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement dated 4 May 2011 regarding the issuance of 102,403 shares under the Nanosonics Deferred Employee Share Plan. It includes a notice under Section 708A(5)(e) of the Corporations Act 2001, confirming compliance with disclosure requirements and providing details about the securities issued. The document also contains an Appendix 3B, which is a standard form used in Australian securities markets to announce new issues of securities and applications for quotation on the ASX. The content focuses on the issuance of shares, terms of the securities, and compliance with regulatory requirements for new share issues. There is no financial performance data, management discussion, or earnings information. The document is not a report but an official announcement of a share issue and related regulatory notice. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2011-05-03 English
Appendix 4C - quarterly 5 pages 964.7KB
Interim / Quarterly Report Classification · 100% confidence The document is titled '4C Statement' and is described as a 'Quarterly Report' for the quarter ended 31 March 2011. It contains detailed consolidated cash flow statements, explanations of cash flows related to operating, investing, and financing activities, reconciliation of cash, and compliance statements. The presence of quarterly financial data and the specific reference to the quarter end date indicate this is a comprehensive interim financial report. The Appendix 4C is a known Australian Securities Exchange (ASX) form used for quarterly cash flow reporting by listed companies. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). The document length (about 15,000 characters) and detailed financial data confirm it is the report itself, not just an announcement or certification.
2011-04-28 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.